A new study published in The Lancet shows that intensive blood pressure management, aiming for levels below 120-130 mmHg, can significantly reduce the risk of heart attack and stroke, though it may increase side effects; personalized treatment strategies are recommended.
To reduce the risk of kidney cancer, maintain a healthy lifestyle by quitting smoking, staying active, controlling blood sugar and blood pressure, staying well hydrated, avoiding toxic chemicals, and monitoring symptoms and kidney health through regular checkups.
A global study conducted in India, known as the TOPSPIN trial, found that three different combination therapies for hypertension are equally effective in reducing blood pressure among South Asian populations. The study, which involved nearly 2000 participants, showed significant blood pressure reductions with all combinations, suggesting that physicians can choose treatments based on availability and cost. This research is particularly relevant for the large South Asian population in the US and highlights the potential for improved hypertension management in underserved groups.
The control of hypertension, a major cause of serious and fatal illnesses, remains a challenge despite numerous efforts. However, a group practice in Ohio called PriMed Physicians has achieved consistent blood pressure control for over 90% of its hypertensive patients for more than a decade. They utilize AI tools and impedance cardiography to determine each patient's unique blood pressure pathophysiology and tailor treatment accordingly. Factors contributing to their success include senior management commitment, informed buy-in from clinicians and patients, precise drug selection based on individual factors, persistent follow-up, and refusal to accept failure. More rigorous clinical trials are needed to validate this approach, which has the potential to significantly reduce healthcare costs and improve patient outcomes.